Mr. Bradley is currently President and General Manager, CNSide Diagnostics, LLC. Previously, Mr. Bradley led the Hematology Business Unit at Abbott Laboratories (NYSE: ABT) as General Manager. Before joining Abbott Labs, Mr. Bradley served as Senior Vice President of Corporate Development and Chief Marketing and Sales Officer of Luminex, Inc. (NASDAQ: LMNX – acquired by Diasorin for $1.8B in 2021). Previously, Mr. Bradley spent 17 years at Beckman Coulter, Inc. (acquired by Danaher (NYSE: DHR) for $6.8B), where he served in roles of increasing responsibility, including global commercial leadership of Beckman Coulter’s flow cytometry business and as the director of the Beckman Coulter CARES initiative, leading the company’s HIV clinical monitoring business in developing regions around the globe. During his tenure as a senior executive in the life science and clinical diagnostics markets, Mr. Bradley has completed the evaluation, market assessment, and successful commercial launch of multiple clinical diagnostics and life science technologies. Mr. Bradley obtained a B.Sc. Immunology and Biochemistry from Monash University, Melbourne, Australia.